Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The InterMune Debacle Post-Script
TheStreet.com
Wednesday, May 5, 2010 - 11:06am
tags:
pirfenidone, InterMune, FDA, Pozen, Gilead Sciences
E&Y: 2009 forever changed the biopharma industry
Fierce Biotech
Wednesday, May 5, 2010 - 11:04am
tags:
Earnst and Young, pharma industry, biotech
Pharmacyclics halves Q3 loss to $3.1M
Bizjournals.com
Wednesday, May 5, 2010 - 11:02am
tags:
earnings, Pharmacyclics
Steve Nissen vs. GlaxoSmithKline
In the Pipeline
Wednesday, May 5, 2010 - 10:31am
tags:
GSK, Steve Nissen
Pfizer and Merck Earnings Impress Investors
Daily Finance
Wednesday, May 5, 2010 - 9:56am
tags:
Pfizer, Merck, earnings
Live from BIO: What do biotech VCs want?
Fierce Biotech
Wednesday, May 5, 2010 - 9:54am
tags:
BIO, biotech, venture capital
J&J Sales Reps Must Ride With Compliance Police
Pharmalot
Wednesday, May 5, 2010 - 9:49am
tags:
JNJ, sales reps, compliance, off-label, Topamax
Alexza files for up to $75M stock sale
Bizjournals.com
Wednesday, May 5, 2010 - 9:44am
tags:
stock offering, Alexza
Cephalon Beats; Updates Guidance
Yahoo/Zacks.com
Wednesday, May 5, 2010 - 9:43am
tags:
Cephalon, guidance, earnings
King Pharma swings to a profit, revenue falls
Marketwatch
Wednesday, May 5, 2010 - 9:42am
tags:
King, earnings
A Plan So Crazy It Just Didn't Work: How J&J Got Busted Selling an Epilepsy Drug as a Weight-Loss Product
BNET Pharma
Wednesday, May 5, 2010 - 9:41am
tags:
epilepsy, JNJ, Topamax, off-label
Merck, Ariad Strike Exclusive License Deal
TheStreet.com
Wednesday, May 5, 2010 - 9:19am
tags:
Merck, Ariad Pharmaceuticals, licensing, ridaforolimus
J&J Failed to Safeguard Children’s Tylenol From Contamination
Bloomberg
Wednesday, May 5, 2010 - 7:45am
tags:
JNJ, contamination, recalls
Novartis to pay $72.5M to settle false claims suit
Yahoo/AP
Wednesday, May 5, 2010 - 7:44am
tags:
Novartis, settlements, Chiron, Tobi
FDA demands new trial for InterMune's pirfenidone
Fierce Biotech
Tuesday, May 4, 2010 - 4:59pm
tags:
FDA, InterMune, pirfenidone
FDA Warns Novartis, Glaxo on Marketing Practices
WSJ Online
Tuesday, May 4, 2010 - 4:58pm
tags:
FDA, Novartis, GSK, warnings
FDA: J&J failed to test Tylenol for contamination
Yahoo/AP
Tuesday, May 4, 2010 - 4:43pm
tags:
FDA, recalls, JNJ
Bristol-Myers board OKs $3B share repurchase
Yahoo/AP
Tuesday, May 4, 2010 - 4:42pm
tags:
Bristol-Myers Squibb, share repurchase
Impax Q1 beats Wall Street view
Reuters
Tuesday, May 4, 2010 - 11:54am
tags:
Impax, earnings
Ironwood offers upbeat PhIII data details on linaclotide
Fierce Biotech
Tuesday, May 4, 2010 - 11:53am
tags:
linaclotide, Ironwood, clinical trials, Forest Labs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.